File size: 371 Bytes
08fd094 | 1 2 3 4 5 6 7 8 9 10 11 12 | [[PAGE:1]] FREQUENTLY ASKED QUESTIONS What is the approved starting dose for the authorised product? 80 mg once daily in first-line metastatic EGFR-positive NSCLC within EU label boundaries. [[PAGE:2]] MISSED DOSE Patient-facing answers must use only approved missed-dose guidance and avoid improvised rescue instructions; advise clinician follow-up when uncertain. |